Bharat Biotech issued a statement on Thursday emphasizing the safety measures taken during the development of its COVID-19 vaccine, Covaxin, amid ongoing discussions about the side effects of Covishield. This follows AstraZeneca’s recent admission in court that its vaccine could “in very rare cases” cause Thrombosis Thrombocytopenia Syndrome (TTS). “Covaxin…
Ram Rajya News
Heralding Ram Rajya in Bharat